Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Eric Bannasch’s Cadian Capital Management Reported 5.22% Passive Stake in $LTXC

Eric Bannasch’s Cadian Capital Management revealed its 5.22% passive stake in LTX-Credence Corp (LTXC) on December 21st. According the SEC filing, now Cadian Capital Management has 2.55 million shares in the stock, which is a 46% increase from its Q3 position of 1.74 million shares. Now LTXC is trading at $5.66, and has lost 24% year to date.

LTX-Credence Corp

There are other hedge fund managers who also took LTXC in the third quarter. Jim Simons’ Renaissance Technologies reported 1.20 million shares, after the firm decreased its position by 7%. Cliff Asness’ AQR Capital Management boosted its position by 3 times and had 987 thousand shares at the end of the third quarter.

Eric Bannasch is a portfolio manager in Cadian Capital. He has a MBA degree in Stanford University Graduate School of Business and a Bachelor’s degree in Stanford University. Cadian Capital has a 13F portfolio of more than $2.4 billon. More than half of the firm’s capital is invested in Technology sector.

According to Google Finance, LTX-Credence Corp “provides focused, automated test equipment (ATE) solutions. It designs, manufactures, markets and services ATE solutions that address the test requirements of the wireless, computing, automotive and consumer market segments. The company’s product portfolio consists of three segment focused, scalable platforms: Diamond Platform, X-Series Platform and ASL Platform. 

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!